2. Аюпова К.Р. Изучение антиоксидантной активности в сыворотке крови пациентов розацеа с учетом клинического течения заболевания. Сборник материалов III Всероссийского конгресса клинической медицины с международным участием им. С.С. Зимницкого. 2022. C. 12–14.

3. Bilalova K.A. Rosacea: features of pathogenesis and therapy. Eur J Natural History. 2022;2:18–21.

4. Xin Lis Dan, Yi Zhang, Yi-Chao Yang, et al. Current research and clinical trends in the pathogenesis of rosacea. Helicon. 2022;8(10):e10874. Doi: 10.1016/j.heliyon.2022.e10874.

5. Аюпова К.Р., Юсупова Л.А. Современные особенности патогенетических механизмов розацеа. Фарматека.2022;(8):43–47.

6. Юсупова Л.А. Современный взгляд на проблему старения кожи. Лечащий врач. 2017;6:75.

7. Юсупова Л.А., Мингазетдинова Н.И. Современное состояние проблемы сухой кожи. Лечащий врач. 2014;5:41.

8. Yusupova L.A. Level sL-selectin in blood serum of patients with schizophrenia comorbidity pyoderma. Eur J Natural History. 2013;3:19–20.

9. Юсупова Л.А. Современное состояние проблемы эксфолиативного дерматита. Лечащий врач. 2019;11:6–8

10. Rashmi Sarkar, Surabhi Sinha. Skin diseases in women. Springer Nature Singapore Pte Ltd. 2022. P. 137–53.

11. Kellen R., Silverberg N.B. Children’s rosacea. Kutis. 2016;98(1):49–53.

12. Cribier B. Rosacea under the microscope: characteristic histological data. J Eur Acad Dermatol Venereol. 2013;27:1336–43. Doi: 10.1111/jdv.12121.

13. Gerd Plewig, Bodo Melnik, Wan Chi Chen. Acne and rosacea of Plevig and Kligman. Springer Nature Switzerland AG, 2019. 670 p.

14. Kucukunal A., Altunay I., Arici J.E., Cerman A.A. Is the effect of smoking on rosacea still something mysterious? Kutan Eye Toxicol. 2016;35(2):110–14. Doi: 10.3109/15569527.2015.1046184.

15. Breton A.L., Trushete F., Veran I., et al. Analysis of the prevalence of smoking in rosacea. J Eur Acad Dermatol Venereol. 2011;25:1112–13. Doi: 10.1111/j.1468-3083.2010.03802.x.

16. Lee S., Cho E., Drucker A.M., et al. Cigarette smoking and the risk of rosacea in women. Am J Epidemiol. 2017;186(1):38–45. doi: 10.1093/aje/kwx054.

17. John Burt-Jones, Chi Leong Go Howard I. Maybach. Rosacea. Springer Nature Switzerland AG. 2020. 152 p.

18. Elewski B.E., Draelos Z., Dreno B., et al. Rosacea – global diversity and optimal outcome: the proposed international consensus of the international expert group on rosacea. J Eur Acad Dermatol Venerol. 2011;25(2):188–200. Doi: 10.1111/j.1468-3083.2010.03751.x.

19. Odom R., Dahl M., Dover J., et al. Standard treatment options for rosacea, part 2: options depending on the subtype. Kutis. 2009;84(2):97–104.

20. Natale F., Cirillo C., Granato C., et al. Exacerbation of rosacea in patients treated with dihydropyridine calcium channel blockers: a clinical observation. Hypertension. 2011;34:790–91. Doi: 10.1038/hr.2011.32.

21. Akin Belli A., Ozbas Gok S., Akbaba G., et al. The relationship between rosacea and insulin resistance and metabolic syndrome. Eur J Dermatol. 2016;26(3):260–64. doi: 10.1684/ejd.2016.2748.

22. Egeberg A., Hansen P.R., Gislason G.H., Thyssen J.P. Clustering of autoimmune diseases in patients with rosacea. J Am Acad Dermatol. 2016;74(4):667–72.e2. Doi: 10.1016/j.jaad.2015.11.004.

23. Kota S., Jammula S., Kota S., et al. Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density. Indian Jay Ortop. 2013;47(4):402–7. Doi: 10.4103/0019-5413.114932.

24. Falay Gur T., Erdemir A., Gurel M., et al. Investigation of the relationship of demodex density with inflammatory response and oxidative stress in rosacea. Arch Dermatol Res. 2018;310(9):759–67. Doi: 10.1007/s00403-018-1857-1.

25. Yildiz A., Gur M., Demirbag R., et al. Paraoxonase and arylesterase activity in patients with and without Dipper hypertension who have not received treatment. Wedge Biochim. 2008;41(10–11):779–84.

26. Takchi Z., Bilgili S.G., Karadag A.S., et al. Decreased activity of paraoxonase and arylesterase in serum in patients with rosacea. J Eur Acad Dermatol Venerol. 2015;29(2):367–70. Doi: 10.1111/jdv.12556.

27. Hua T.K., Chung Pi., Chen Yi Jay, et al. Concomitant cardiovascular diseases in patients with rosacea: a nationwide case-control study conducted in Taiwan. J Am Acad Dermatologist. 2015;73(2):249–54. Doi: 10.1016/j.jaad.2015.04.028.

28. Rainer B.M., Fischer A.H., Luz Felipe Da Silva D., et al. Rosacea is associated with chronic systemic skin diseases depending on the severity: case-control study results. J Am Acad Dermatol. 2015;73:604–8. Doi: 10.1016/j.jaad.2015.07.009.

29. Powell F.C. Clinical practice. Rosacea. N Engl J Med. 2005;352:793–803. Doi: 10.1056/NEJMcp042829.

30. Egeberg A., Hansen P.R., Gislason G.H., Thyssen J.P. Assessment of the risk of cardiovascular disease in patients with rosacea. J Am Acad Dermatol. 2016;75(2):336–39. Doi: 10.1016/j.jaad.2016.02.1158.

31. Spoendlin J., Voegel J.J., Jick S.S., Meier C.R. Antihypertensive drugs and the risk of incident rosacea. Br J Dermatol. 2014;171(1):130–36. Doi: 10.1111/bjd.12838.

32. Libby P., Ridker P.M., Mazeri A. Inflammation and atherosclerosis. Blood circulation. 2002;105(9):1135–43. Doi: 10.1161/hc0902.104353.

33. Duman N., Ersoy Evans S., Atakan N. Rosacea and cardiovascular risk factors: a case control study. J Eur Acad Dermatol Venereol. 2014;28(9):1165–69. Doi: 10.1111/jdv.12234.

34. Edfeldt K., Agerbert B., Rottenberg M.E., et al. Participation of antimicrobial peptide LL-37 in the development of atherosclerosis in humans. Arteriosclerotic thrombus Vasc Biol. 2006;26(7):1551–17. Doi: 10.1161/01.ATV.0000223901.08459.57.

35. McNess M., Darrington P., McNess B. The role of paraoxonase 1 activity in the development of cardiovascular diseases. Am J Cardiovascular drugs. 2004;4(4):211–17. Doi: 10.2165/00129784-200404040-00002.

36. Doring Y., Drechsler M., Vanta S., et al. The absence of neutrophilic spasm reduces atherosclerosis in mice. Circ Res. 2012;110(8):1052–56. Doi: 10.1161/CIRCRESAHA.112.265868.

37. Yu Ri Woo, Ji Hong Lim, Dae Ho Cho, Hyun Jeong Park. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition. Int J Mol Sci. 2016;17:1562. Doi: 10.3390/ijms17091562.

38. Belli A.A., Altun I., Altun I. Thickness of carotid intima and epicardial fat in rosacea: a cross–sectional study. An Bras Dermatol. 2017;92(6):820–25.Doi: 10.1590/abd1806-4841.20176832.